Victoza: Implications for New York Alzheimer’s Patients
A group of researchers from Lancaster University has made a groundbreaking discovery. A drug used in the treatment of Type 2 diabetes could likewise reverse memory loss in Alzheimer’s patients. Accordingly, the scientists treated transgenic mice with liraglutide. This injectable drug, also known as Victoza, can control glucose levels in Type 2 diabetic patients. However,…